Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-β1 involves furin-convertase

Cardiovascular Research

Volumn 63, Issue 1, 2004, Pages 87-97

  Stawowy, Philipp ^a   Margeta, Christian ^a   Kallisch, Heike ^a   Seidah, Nabil G ^b   Chrétien, Michel ^c   Fleck, Eckart ^a   Graf, Kristof ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Extracellular matrix; Growth factors; Matrix metalloproteinases; Remodelling

Indexed keywords

ANGIOTENSIN; BREFELDIN A; FURIN; GELATINASE A; ILOMASTAT; MATRIX METALLOPROTEINASE 14; METALLOPROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; FIBROBLAST; GOLGI COMPLEX; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BREFELDIN A; CELL MOVEMENT; CELLS, CULTURED; DIPEPTIDES; FIBROBLASTS; FURIN; GOLGI APPARATUS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MYOCARDIUM; PROPROTEIN CONVERTASES; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

EID: 2942571336     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.03.010     Document Type: Article

References (48)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79:1999;215-262
2. Manabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis. Involvement in cardiac hypertrophy. Circ. Res. 91:2002;1103-1113
3. Gabbiani G. Evolution and clinical implications of the myofibroblast concept. Cardiovasc. Res. 38:1998;545-548
4. Petrov V., Fagard R., Lijnen P. Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblast to myofibroblasts. Hypertension. 39:2002;258-263
5. Kuwahara F., Kai H., Tokuda K., et al. Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 106:2002;130-135
6. Mogford J.E., Tawil N., Chen A., Gies D., Xia Y., Mustoe T.A. Effects of age and hypoxia in TGFbeta1 receptor expression and signal transduction in human dermal fibroblasts: impact on cell migration. J. Cell. Physiol. 190:2002;259-265
7. Leeb S.N., Vogl D., Falk W., Scholmerich J., Rogler G., Gelbmann C.M. Regulation of migration of human colonic myofibroblasts. Growth Factors. 20:2002;81-91
8. Spinale F., Coker M., Bond B., Zellner J. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential target. Cardiovasc. Res. 46:2000;225-238
9. Yuan W., Varga J. Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J. Biol. Chem. 276:2001;38502-38510
10. Overall C., Wrana J., Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J. Biol. Chem. 266:1991;14064-14071
11. Spinale F.G., Coker M.L., Heung L.J., et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 102:2000;1944-1949
12. Fedak P., Altamentova S., Weisel R., et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am. J. Physiol, Heart Circ. Physiol. 284:2003;H626-H634
13. Klappacher G., Franzen P., Haab D., et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am. J. Cardiol. 75:1995;913-918
14. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Circulation. 107:2003;984-991
15. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitor of metalloproteinases. Structure, function and biochemistry. Circ. Res. 92:2003;827-839
16. Yana I., Weiss S.J. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell. 11:2000;2387-2401
17. Wang X., Pei D. Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase. J. Biol. Chem. 276:2001;35953-35960
18. Kang T., Nagase H., Pei D. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res. 62:2002;675-681
19. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev., Mol. Cell Biol. 3:2002;753-766
20. Seidah N.G., Mbikay M., Marcinkiewicz M., Chrétien M. The mammalian precursor convertases: paralogs of the subtilisin/kexin family of calcium-dependent serine proteinases. Hook V.Y.H. Proteolytic and cellular mechanisms in prohormone and proprotein processing. 1998;49-76 R.G. Landes, Georgetown, TX, USA
21. Henrich S., Cameron A., Bourenkov G.P., et al. The crystal structure of the proprotein convertase furin explains its stringent specificity. Nat. Struct. Biol. 10:2003;520-526
22. Bassi D., Lopez De Cicco R., Mahloogi H., Zucker S., Thomas G., Klein-Szanto A. Furin inhibition results in absent or decreased invasiveness and tumorgenicity of human cancer cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10326-10331
23. McMahon S., Laprise M.-H., Dubois C.M. Alternative pathway for the role of furin in tumor cell invasion process. Enhanced MMP-2 levels through bioactive TGFβ Exp. Cell Res. 291:2003;326-339
24. Dubois C.M., Blanchette F., Laprise M.H., Leduc R., Grondin F., Seidah N.G. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am. J. Pathol. 158:2001;305-316
25. Roebroek A., Umans L., Pauli I., et al. Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase furin. Development. 125:1998;4863-4876
26. Iwami K., Ashizawa N., Do Y.S., et al. Comparison of ang II with other growth factors on egr-1 and matrix gene expression in cardiac fibroblasts. Am. J. Physiol, Heart Circ. Physiol. 270:1996;H2100-H2107
27. s6-kinase activation in vascular smooth muscle cells. Hypertension. 39:2002;399-404
28. 3 integrin expression in rat neonatal cardiac fibroblasts. Hypertension. 35:2000;978-984
29. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type I pre-pro-transforming growth factor beta to the mature polypeptide. Mol. Cell. Biol. 8:1988;4162-4168
30. Campbell S.E., Katawa L.C. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 7:1997;1947-1958
31. Siwik D., Chang D., Colucci W. Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 86:2000;1259-1265
32. Dinter A., Berger E.G. Golgi-disturbing agents. Histochem. Cell Biol. 109:1998;571-590
33. Rozanov D.V., Strongin A.Y. Membrane type-1 matrix metalloproteinase functions as a proprotein self-convertase. Expression of the latent zymogen in pichia pastoris, autolytic activation, and the peptide sequence of the cleavage forms. J. Biol. Chem. 278:2003;8257-8260
34. Eghbali M. Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium. Cell Tissue Res. 256:1989;553-556
35. Sun Y., Zhang J.Q., Zhang J., Ramires F.J. Angiotensin II transforming growth factor-β1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 30:1998;1559-1569
36. Öklü R., Hesketh R. The latent transforming growth factor β binding protein (LTBP) family. Biochem. J. 352:2000;601-610
37. Antonelli-Orlidge A., Saunders K.B., Smith S.R., D'Amore P.A. An activated form of transforming growth factor beta is produced by coculture of endothelial cells and pericytes. Proc. Natl. Acad. Sci. U. S. A. 86:1989;4544-4548
38. Cheng S., Lovett D.H. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am. J. Pathol. 162:2003;1937-1949
39. Hallenberger S., Bosch V., Angeliker H., et al. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 360:1992;358-361
40. Flanders K.C., Holder M.G., Winokur T.S. Autoinduction of mRNA and protein expression for transforming growth factor-beta 1 in cultured cardiac cells. J. Mol. Cell. Cardiol. 27:1995;805-812
41. Jiang A., Lehti K., Wang X., Weiss S., Keski-Oja J., Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 98:2001;13693-13698
42. Deten A., Holzl A., Leicht M., Barth W., Zimmer H.G. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J. Mol. Cell. Cardiol. 33:2001;1191-1207
43. Hayashidani S., Tsutsui H., Ikeuchi M., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol, Heart Circ. Physiol. 285:2003;H1229-H1235
44. 1 integrins. Eur. J. Cell Biol. 80:2001;68-77
45. Ratnikov B.I., Rozanov D.V., Postnova T.I., et al. An alternative processing of integrin αv subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 277:2002;7377-7385
46. Stawowy P., Kallisch H., Veinot J.P., et al. Endoproteolytic activation of αv integrin by proprotein convertases PC5 is required for VSMC adhesion and integrin-dependent signaling. Circulation. 109:2004;770-776
47. Guo C., Piacentini L. Type I collagen-induced MMP-2 activation coincidents with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. J. Biol. Chem. 278:2003;46699-46708
48. Sawada Y., Inoue M., Kanda T., et al. Co-elevation of brain natriuretic peptide and proprotein-processing endoprotease furin after myocardial infarction in rats. FEBS Lett. 400:1997;177-182